NovioSense's artist conception of its device in use.
November 20, 2018
Last week, Alphabet subsidiary Verily Life Sciences announced the end, at least for the foreseeable future, of its glucose-sensing contact lens collaboration with Novartis.
Verily CTO Brian Otis gave his thoughts in a blog post at the time, stressing the learnings the company got from the project. In a recent interview with MobiHealthNews, Novartis Global Head of Digital Development Jacob LaPorte...
November 16, 2018
Four years after announcing an ambitious — and often ridiculed — project to create a glucose-sensing contact lens along with Novartis subsidiary Alcon, Alphabet's Verily is throwing in the towel, the company announced in a blog post today. It will continue to work on two other medical contact lens projects, aimed at presbyopia and cataract surgery recovery.
"Our clinical work on the glucose-...
(L to R) Moderator Scott Thiel, Pear Therapeutics' Dan Amor, Verily's Afia Asamoah, Tidepool's Howard Look, and Johnson & Johnson's Eduardo Sanchez (photo by Jonah Comstock)
October 19, 2018
Attendees to the Connected Health Conference in Boston this week got a sneak peek into the workings of the FDA's much-discussed Pre-Cert program. In a panel discussion at the event, representatives from Verily, Pear Therapeutics, Tidepool, and Johnson & Johnson candidly discussed their experiences so far with the program, describing an evolving process that is collaborative and rigorous.
August 23, 2018
Psychiatry has long stood as one of the more subjective areas of care, but new technologies and large-scale data generation and analysis may offer a more quantifiable approach to mental health treatment.
In a recently published perspective, a group of Verily researchers and Former FDA Commissioner Dr. Robert Califf called for the psychiatric field to embrace digital sensors and the data sciences...
July 11, 2018
Alphabet subsidiary Verily is teaming up with well-known sleep company ResMed to form a new venture that will focus on developing sleep apnea treatments and connected health products.
The latest venture will look at the health and financial impacts of sleep apnea. The companies plan on developing new software that will have advanced analytics and machine learning capabilities, Dr. Carlos Nunez,...
June 28, 2018
Dr. Joshua Mandel has left his position at Alphabet's Verily as health IT ecosystem lead for a position as chief architect at Microsoft Healthcare. Mandel isn't the only big name Microsoft just picked up; Jim Weinstein, former CEO of Dartmouth-Hitchcock, joined the company at the same time as VP and head of innovation and health equity.
"Jim and Josh join us at an exciting time, as healthcare...
June 8, 2018
The road to digital innovation in the pharma and healthcare space is going to take players across industries — from tech developers and engineers to researchers and clinicians, according to a panel of digital-focused VPs speaking at BIO 2018 in Boston.
Tech is opening up new avenues in research and development, as well as access to data from EHRs and other databases. In the past, the healthcare...
May 17, 2018
Sanofi’s approach to digital health is broad, but focused, Rachel Sha, the company’s vice president of digital business development and licensing, told MobiHealthNews in an interview ahead of the upcoming BIO 2018 conference in Boston, where Sha will be speaking on a range of digital health-related topics.
“At Sanofi we’re lucky in the sense that we have a very clear set of digital priorities...
May 16, 2018
Verily Life Sciences has filed a patent application for a “smart diaper” carrying a sensor for detecting and differentiating between feces and urine. The diaper would also contain a transmitter capable of wirelessly communicating whether waste is present to a separate device via Bluetooth, WiFi, or other means.
The patent application, spotted by Jenny Morber (@JRMorber), was filed by Verily in...
May 14, 2018
Verily researchers have built prototype devices for painless blood collection that uses a system of “exploding” micro-needles, magnets, and potentially a blood storage chamber, CNBC reports. Information on the device was received from several anonymous sources, who CNBC said did not want to be named as the project is still unannounced.
“Several sources aware of the company's plans say the device...